FOXO3 and bronchopulmonary dysplasia: The ratio of FOXO3-P to FOXO3 was significantly elevated in the WT BPD group compared to the WT RA group and significantly decreased in the miR-451 inhibitor treated BPD mice, compared to WT BPD mice (Fig. 8a and d).